← Leaderboards
Jian Huang
Coriell Institute For Medical Research
$5,521,211
Attributed
$5,658,399
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,658,399 · 6
By mechanism
R01$4,026,476 · 2
R00$726,331 · 1
R41$406,403 · 1
R21$274,377 · 1
K99$224,812 · 1
Top collaborators
- Peter S Klein2 shared
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsHematological DiseaseIn VivoKnock-OutPlayHematopoieticCellsGenesLoss Of FunctionInsightSelf-RenewalHematopoietic Stem CellsLeukemiaLibrariesResponseSignal TransductionStem CellsBone Marrow TransplantationLearningBlood CellsPublishingMolecularHematopoiesisSignal Pathway
Grant awards (18)
The role of GSK3/PPAR-/mitophagy pathway in regulating hematopoia$498,785
R01 · FY2025 · HL · contact PI
Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML$405,192
R01 · FY2025 · CA · contact PI
Expand human umbilical cord blood hematopoietic stem cells with PPAR-a agonists$127,501
R21 · FY2025 · HL · contact PI
The role of GSK3/PPAR-/mitophagy pathway in regulating hematopoia$488,809
R01 · FY2024 · HL · contact PI
Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML$387,863
R01 · FY2024 · CA · contact PI
Expand human umbilical cord blood hematopoietic stem cells with PPAR-a agonists$146,876
R21 · FY2024 · HL · contact PI
The role of GSK3/PPAR-/mitophagy pathway in regulating hematopoia$511,939
R01 · FY2023 · HL · contact PI
Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML$400,445
R01 · FY2023 · CA · contact PI
The role of GSK3/PPAR-/mitophagy pathway in regulating hematopoia$524,381
R01 · FY2022 · HL · contact PI
Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML$400,445
R01 · FY2022 · CA · contact PI
Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML$408,617
R01 · FY2021 · CA · contact PI
Small-molecule combinationsexpand hematopoietic stem cell ex vivo and in vivo$203,302
R41 · FY2020 · HL · contact PI
Small-molecule combinationsexpand hematopoietic stem cell ex vivo and in vivo$203,101
R41 · FY2019 · HL · contact PI
Signaling pathways regulated by GSK3 in hematopoietic stem cell$245,263
R00 · FY2015 · HL · contact PI
Signaling pathways regulated by GSK3 in hematopoietic stem cell$244,020
R00 · FY2014 · HL · contact PI
Signaling pathways regulated by GSK3 in hematopoietic stem cell$237,048
R00 · FY2013 · HL · contact PI
Signaling pathways regulated by GSK3 in hematopoietic stem cell$112,406
K99 · FY2012 · HL · contact PI
Signaling pathways regulated by GSK3 in hematopoietic stem cell$112,406
K99 · FY2011 · HL · contact PI